Search for:
  • Home/
  • Tag: FDA drug labeling compliance

FDA Drug Listing & NDC Number Assignment (SPL Submissions) – XPRO America

The US FDA Drug Listing process is a mandatory compliance requirement for all human and veterinary drug products marketed in the United States. Under 21 CFR Part 207, every registered drug establishment must submit detailed information about each drug product they manufacture, repack, relabel, or distribute. This process ensures the [...]

ANDA & NDA Submissions Support for FDA Drug Approvals – XPRO America

Bringing a pharmaceutical product to the U.S. market requires rigorous regulatory approval by the U.S. Food and Drug Administration (FDA). For drug manufacturers, this process involves filing either an Abbreviated New Drug Application (ANDA) for generic drugs or a New Drug Application (NDA) for novel, innovative drugs. The ANDA pathway [...]